Canada at a glance
- Population
- 41.7 million 2025
- Life expectancy at birth
- 82.1 years, 2024
- People aged 65 and over
- 20.3 % of people, 2025
- Health spending per person
- 6,378 US$ per person, 2024
- Doctors
- 2.82 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
Canada Cancer Genomic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.14 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.08 Bn | — | — |
| 2025 (base) | $1.21 Bn | +$129.2 Mn | — |
| 2026 (forecast) | $1.35 Bn | +$144.7 Mn | +12% |
| 2027 (forecast) | $1.51 Bn | +$162.1 Mn | +25.4% |
| 2028 (forecast) | $1.69 Bn | +$181.5 Mn | +40.5% |
| 2029 (forecast) | $1.90 Bn | +$203.3 Mn | +57.4% |
| 2030 (forecast) | $2.13 Bn | +$227.7 Mn | +76.2% |
| 2031 (forecast) | $2.38 Bn | +$255.0 Mn | +97.4% |
| 2032 (forecast) | $2.67 Bn | +$285.6 Mn | +121.1% |
| 2033 (forecast) | $2.99 Bn | +$319.9 Mn | +147.6% |
| 2034 (forecast) | $3.34 Bn | +$358.3 Mn | +177.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.21 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.34 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, sample and end user (see all) |
| Key players | Roche, Myriad Genetics, Inc., Illumina, Inc., Guardant Health, Inc., Caris Life Sciences and 1 more (see all) |
| Regulator in Canada | Health CanadaSource: Health Canada. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cancer genomic tests read the DNA of tumours or blood to find mutations that guide treatment or show inherited cancer risk.
Key segments of the cancer Genomic Testing market include test (Comprehensive Genomic Profiling, Hereditary Cancer Panels and Single-Gene Tests) and sample (Tissue, Blood and Saliva).
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the cancer Genomic Testing market. Faster approvals and new combinations are improving survival.
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the cancer Genomic Testing market.
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the cancer Genomic Testing market, especially in low- and middle-income countries.
The cancer Genomic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.[2]
[1] Health Canada. Checked 14 Nov 2026.
[2] Health Canada. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cancer Genomic Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.
What doctors and scientists are doing in Cancer Genomic Testing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Canada · 2 shared keywords
Canada · 1 shared keyword
Canada · 1 shared keyword
Canada
Canada
Canada
Pharmaceuticals · Canada
Digital Health · Canada
Healthcare Services · Canada
Pharmaceuticals · Canada
Pharmaceuticals · Canada
Healthcare Services · Canada